self-amplifying RNA vaccine(VLP Therapeutics)

N/A

Report date: 2023/11/20 17:34:36

Base Information

Drug Nameself-amplifying RNA vaccine(VLP Therapeutics)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVlp TherapeuticsDenka Co LtdBiken
China Registration ClassN/A

Develop Information

Active CompaniesBikenVlp TherapeuticsDenka Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A